| Identification | Back Directory | [Name]
(±)-(R*,S*)-4-[3-(4-Fluorophenyl)-2-hydroxy-1-(1,2,4-triazol-1-yl)propyl]benzonitrile | [CAS]
160146-17-8 | [Synonyms]
MPV 2213
MPV-2213
(±)-(R*,S*)-4-[3-(4-Fluorophenyl)-2-hydroxy-1-(1,2,4-triazol-1-yl)propyl]benzonitrile
rel-4-[(1R,2S)-3-(4-Fluorophenyl)-2-hydroxy-1-(1H-1,2,4-triazol-1-yl)propyl]benzonitrile
Benzonitrile, 4-[(1R,2S)-3-(4-fluorophenyl)-2-hydroxy-1-(1H-1,2,4-triazol-1-yl)propyl]-, rel- | [Molecular Formula]
C18H15FN4O | [MDL Number]
MFCD09838476 | [MOL File]
160146-17-8.mol | [Molecular Weight]
322.34 |
| Hazard Information | Back Directory | [Uses]
Finrozole (MPV-2213ad) is a nonsteroidal, orally active and competitive aromatase enzyme inhibitor. Finrozole can be used for urinary symptoms research[1]. | [References]
[1] O Ahokoski, et al. Pharmacokinetics of finrozole (MPV-2213ad), a novel selective aromatase inhibitor, in healthy men. Br J Clin Pharmacol. 2001 Dec;52(6):702-4. DOI:10.1046/j.0306-5251.2001.01488.x |
|
|